Trademark: CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM
Proof of use for CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM
We do not have any records of a proof of use for CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM at this moment.
Possible trademark infringements of CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM
Basic Information about CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM
- Serial Number
- 97795022
- Filing Date
- 14 Feb 2023
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM on the blockchain with WikiTrademarks.io.
- First use of CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM anywhere
- CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM was first used on 01 Feb 2023 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM CLINICAL TRIAL PLATFORM?
1. Scleroderma Research Foundation San Francisco CA
Correspondent
- J. Scott Gerien DICKENSON, PEATMAN & FOGARTY
- 1500 FIRST STREET, STE 200
- NAPA, CA 94559
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io